(Información remitida por la empresa firmante)
Logo – https://mma.prnewswire.com/media/1927957/Renexxion_Ireland_Logo.jpgLogo — https://mma.prnewswire.com/media/1927956/Dr_Falk_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/renexxion-ireland-ltd-y-dr-falk-pharma-gmbh-anuncian-el-inicio-de-un-estudio-de-fase-ii-de-naronaprida-301746638.html